RxDoctor Payments Data

Michael Crowe, MD

MOHS-Micrographic Surgery · Owensboro, KYNPI 1477667038

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.2% of the total across 64 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by AbbVie at 41.8% of the total.

$1,255in general payments, 2019–2025

Across 64 payments — averaging $19.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$524
  • Novartis$138
  • E.r. Squibb & Sons, L.L.C.$86
  • Lilly USA, LLC$80
  • Johnson & Johnson$74
  • Regeneron Healthcare Solutions, Inc.$56
  • plus $296 from 9 others

What the payments were for

  • Food & beverage$1,20796%
  • Education$484%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

Too few mohs-micrographic surgery providers in Kentuckyto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$1,641,112
Medicare patients
1,179
Services billed
22,860

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent SyringeDupilumab12$44,852
Triamcinolone Acetonide548$4,451
Fluocinonide-EFluocinonide/Emollient Base29$2,814
Ketoconazole109$2,393
Doxycycline Hyclate107$2,391
Fluocinonide48$1,973
Tacrolimus14$1,773
Fluocinolone Acetonide25$1,562
Hydrocortisone288$1,470
Clobetasol Propionate35$1,408
Desonide16$1,348
ValacyclovirValacyclovir Hcl50$1,148
Dapsone15$1,105
Metronidazole20$1,082
Cefdinir50$816

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Owensboro

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →